Single-Use Bioreactors Market Report Scope & Overview:

The Single-Use Bioreactors Market Size was valued at USD 3872.40 million in 2023 and is expected to reach USD 13784.83 million by 2031 and grow at a CAGR of 17.2% over the forecast period 2024-2031.

Due to their great efficiency, single-use bioreactors are ideal for the manufacturing of biopharmaceutical products. They have advanced significantly in recent years as a result of firms' tireless attempts to disseminate goods. They may be seen working on sensor systems, designs, stirring mechanisms, and single-use bioreactor film technology.

Single-Use Bioreactors Market Revenue Analysis

Get more information on Single-Use Bioreactors Market - Request Sample Report

The growing acceptance of single-use bioreactors among small businesses and start-ups, reduced automation complexity, ease of agriculture of marine organisms, reduced energy and water consumption, the growing biologics market, technological advancements in single-use bioreactors, and the growth of biopharmaceutical research and development are all factors driving the market forward. However, obstacles such as single-use bioreactor administration challenges and worries about leachables and extractables are projected to stymie market expansion in the foreseeable term.

Furthermore, license expiration and emerging markets are projected to generate favorable new chances for the single-use bioreactors market to flourish. Despite this, one of the main difficulties for the growth of single-use bioreactors during the projection period is projected to be the desire for improved single-use sensors and the standardization of single-use layouts.



  • Increase in demand for biopharmaceutical

  • A significant portion of small- and mid-scale biopharmaceutical production

  • Single-use system


  • Emerging countries market

  • Availability of less severe regulatory rules

  • Low-cost trained workforce


  • Availability of sensors that are dependable, accurate, and affordable.

  • The quality of available sensors does not meet GMP requirements.


Coronavirus is a recently distinguished novel Corona that causes an irresistible affliction. Coronavirus, which was generally obscure until the episode in Wuhan, China, in December 2019, has gone from a local issue to a worldwide pandemic in only half a month. In light of the novel COVID pandemic, numerous biopharmaceutical organizations are quickly creating antibodies. Because of the novel COVID pandemic, numerous biopharmaceutical organizations are quickly creating antibodies. Moderna Therapeutics, for example, has a messenger RNA vaccine in Phase I studies, Inovio Pharmaceuticals has a DNA vaccine in human trials, and Novavax is working on a vaccine based on its recombination protein nanoparticle platform. If these programs have passed their trials, single-use equipment and systems will be used to support clinical and commercial manufacturing platforms.

In the quest to produce a coronavirus vaccine, many prominent single-use bioreactor manufacturers are presently collaborating with businesses that have a vaccine in development or are already in clinical trials. Sartorius, for instance, has supported CanSino Biologics Inc. what's more, Maj. Gen. Chen Wei's group at China's Academy of Military Medical Sciences' Institute of Bioengineering in the formation of the primary antibody up-and-comer against the new COVID SARS-CoV-2 to enter clinical preliminaries. Here and there, this affects the SUB market. In the bioprocessing solutions market, the impact of the coronavirus crisis on supply chains, manufacturing, and shipments to consumers has been manageable until now. Predictability in the short and medium-term is severely limited and has little impact.


By Product:

The single-use bioreactors market is disengaged into three classes: single-use bioreactors structure, single-use media pack, and single-use filtration get-togethers.

By Type:

Stirred tank single-use bioreactors, bubble column single-use bioreactors, and wave-induced single-use bioreactors are the three types of single-use bioreactors available.

By Molecule Type:

The single-use bioreactors market is divided into monoclonal antibodies (MAbs), vaccines, stem cells, gene-modified cells, and other molecules.

By Cell Type:

The single-use bioreactors market is divided into mammalian cells, bacterium cells, yeast cells, and other cells based on cell type.

By Application

The single-use bioreactors market is divided into three categories,

research and development, process development, and bioproduction.


By Product

  • Single-use Bioreactor Systems

  • Single-use Filtration Assemblies

  • Single-use Media Bags

  • Other

By Type

  • Stirred-tank SUBs

  • Bubble-column SUBs

  • Wave-induced SUBs

  • Other

By type of cell

  • Mammalian Cells

  • Yeast Cells

  • Bacterial Cells

  • Other Cells (Insect and plant cells)

By Molecule Type

  • Monoclonal Antibodies

  • Gene-modified cells

  • Vaccines

  • Stem Cells

  • Other

By Application

  • Research and Development (R&D)

  • Bioproduction

  • Process Development

By End User

  • Pharmaceutical & Biopharmaceutical Companies

  • Academic & Research Institutes

  • CROs & CMOs


The market for single-use bioreactors was dominated by North America, followed by Europe. A significant portion of the North American topographical fragment can be ascribed to the presence of a deep-rooted biopharmaceutical industry as well as significant members in the single-use bioreactors market.

Single-Use Bioreactors Market By Region

Need any customization research on Single-Use Bioreactors Market - Enquiry Now


North America

  • USA

  • Canada

  • Mexico


  • Germany

  • UK

  • France

  • Italy

  • Spain

  • The Netherlands

  • Rest of Europe


  • Japan

  • south Korea

  • China

  • India

  • Australia

  • Rest of Asia-Pacific

The Middle East & Africa

  • Israel

  • UAE

  • South Africa

  • Rest of Middle East & Africa

Latin America

  • Brazil

  • Argentina

  • Rest of Latin America


The Major Players Thermo Fisher Scientific, Danaher, Sartorius Stedim Biotech, Merck KgaA, Getinge AB, Celltainer Biotech BV, Eppendorf AG, PBS Biotech Inc., Solida Biotech GmbH, Cellexus, Distek Inc., Able Corporation & Biott Corporation, ABEC, G&G Technologies Inc., Satake Chemical Equipment Mfg Ltd., bbi-biotech GmbH, Stobbe Pharma GmbH and Other Players.

Danaher-Company Financial Analysis

Company Landscape Analysis

Single-Use Bioreactors Market Report Scope:
Report Attributes Details
Market Size in 2023  US$ 3872.40 million
Market Size by 2031  US$ 13784.83 million
CAGR  CAGR of 17.2% From 2024 to 2031
Base Year  2023
Forecast Period  2024-2031
Historical Data  2020-2022
Report Scope & Coverage Market Size, Segments Analysis, Competitive  Landscape, Regional Analysis, DROC & SWOT Analysis, Forecast Outlook
Key Segments • By Product (Single-use Bioreactor Systems, Single-use Filtration Assemblies, Single-use Media Bags, Other)
• By Type (Stirred-tank SUBs, Bubble-column SUBs, Wave-induced SUBs, Other SUBs )
• By Type of Cell (Mammalian Cells, Yeast Cells, Bacterial Cells, Other Cells)
• By Molecule Type (Monoclonal Antibodies, Gene-modified cells, Vaccines, Stem Cells, Other Molecules)
• By Application (R&D, Bioproduction, Process Development)
• By End User (Pharmaceutical & Biopharmaceutical Companies, Academic & Research Institutes, CROs & CMOs)
Regional Analysis/Coverage North America (USA, Canada, Mexico), Europe
(Germany, UK, France, Italy, Spain, Netherlands,
Rest of Europe), Asia-Pacific (Japan, South Korea,
China, India, Australia, Rest of Asia-Pacific), The
Middle East & Africa (Israel, UAE, South Africa,
Rest of Middle East & Africa), Latin America (Brazil, Argentina, Rest of Latin America)
Company Profiles Thermo Fisher Scientific, Danaher, Sartorius Stedim Biotech, Merck KgaA, Getinge AB, Celltainer Biotech BV, Eppendorf AG, PBS Biotech Inc., Solida Biotech GmbH, Cellexus, Distek Inc., Able Corporation & Biott Corporation, ABEC, G&G Technologies Inc., Satake Chemical Equipment Mfg Ltd., bbi-biotech GmbH, Stobbe Pharma GmbH.
DRIVERS • Increase in demand for biopharmaceutical
• A significant portion of small- and mid-scale biopharmaceutical production
• Single-use system
OPPORTUNITIES • Emerging countries market
• Availability of less severe regulatory rules
• Low-cost trained workforce.

Frequently Asked Questions

Ans: The single-Use Bioreactors market is expected to grow at a CAGR of 17.2% over the forecast period 2024-2031.

Ans: The Single-Use Bioreactors Market size was valued at US$ 3872.40 million in 2023.

Single-Use Bioreactors Market is divided into two segments and they are by Product, By type, by type of cell, by molecule, by application, and by End-user

The market for single-use bioreactors was dominated by North America, followed by Europe.

Manufacturer and service provider, research institutes, university, and private libraries, suppliers, and distributors.

Table of Contents

1. Introduction

1.1 Market Definition 

1.2 Scope

1.3 Research Assumptions

2. Research Methodology

3. Market Dynamics

3.1 Drivers

3.2 Restraints

3.3 Opportunities

3.4 Challenges

4. Impact Analysis

4.1 COVID-19 Impact Analysis

4.2 Impact of Ukraine- Russia war

4.3 Impact of ongoing Recession

4.3.1 Introduction

4.3.2 Impact on major economies US Canada Germany France United Kingdom China Japan South Korea Rest of the World

5. Value Chain Analysis

6. Porter’s 5 forces model

7.  PEST Analysis

8. Single-Use Bioreactors Market Segmentation, by Produc

8.1 Single-use Bioreactor Systems

8.2 Single-use Filtration Assemblies

8.3 Single-use Media Bags

8.4 Other

9. Single-Use Bioreactors Market Segmentation, by Type

9.1 Stirred-tank SUBs

9.2 Bubble-column SUBs

9.3 Wave-induced SUBs

9.4 Other

10. Single-Use Bioreactors Market Segmentation by Type of Cell

10.1 Mammalian Cells

10.2 Yeast Cells

10.3 Bacterial Cells

11. Single-Use Bioreactors Market Segmentation, by Molecule Type

11.1    Monoclonal Antibodies

11.2    Gene-modified cells

11.3    Vaccines

11.4    Stem Cells

11.5    Other

12. Single-Use Bioreactors Market Segmentation by Application

12.1    Research and Development (R&D)

12.2    Bioproduction

12.3    Process Development

13. Single-Use Bioreactors Market Segmentation by End User

13.1    Pharmaceutical & Biopharmaceutical Companies

13.2    Academic & Research Institutes

13.3    CROs & CMOs

14. Regional Analysis

14.1 Introduction

14.2 North America

14.2.1 USA

14.2.2 Canada

14.2.3 Mexico

14.3    Europe

14.3.1 Germany

14.3.2 UK

14.3.3 France

14.3.4 Italy

14.3.5 Spain

14.3.6 The Netherlands

14.3.7 Rest of Europe

14.4    Asia-Pacific

14.4.1 Japan

14.4.2 South Korea

14.4.3 China

14.4.4 India

14.4.5 Australia

14.4.6 Rest of Asia-Pacific

14.5    The Middle East & Africa

14.5.1 Israel

14.5.2 UAE

14.5.3 South Africa

14.5.4 Rest

14.6    Latin America

14.6.1 Brazil

14.6.2 Argentina

14.6.3 Rest of Latin America

15. Company Profiles

15.1 Thermo Fisher Scientific 

 15.1.1 Financial

15.1.2 Products/ Services Offered

15.1.3 SWOT Analysis

15.1.4 The SNS view

15.2 Danaher

15.3 Sartorius Stedim Biotech

15.4 Merck KgaA

15.5 Getinge AB

15.6 Celltainer Biotech BV

15.7 Eppendorf AG

15.8 PBS Biotech Inc

15.9 Solida Biotech GmbH

15.10 Cellexus, Distek Inc

15.11 Able Corporation & Biott Corporation

15.12 ABEC

15.15 G&G Technologies Inc

15.15 Satake Chemical Equipment Mfg., Ltd

15.15 bbi-biotech GmbH

15.16 Stobbe Pharma GmbH

16. Competitive Landscape

16.1 Competitive Benchmark

16.2 Market Share Analysis

16.3 Recent Developments

17. Conclusion

An accurate research report requires proper strategizing as well as implementation. There are multiple factors involved in the completion of good and accurate research report and selecting the best methodology to compete the research is the toughest part. Since the research reports we provide play a crucial role in any company’s decision-making process, therefore we at SNS Insider always believe that we should choose the best method which gives us results closer to reality. This allows us to reach at a stage wherein we can provide our clients best and accurate investment to output ratio.

Each report that we prepare takes a timeframe of 350-400 business hours for production. Starting from the selection of titles through a couple of in-depth brain storming session to the final QC process before uploading our titles on our website we dedicate around 350 working hours. The titles are selected based on their current market cap and the foreseen CAGR and growth.


The 5 steps process:

Step 1: Secondary Research:

Secondary Research or Desk Research is as the name suggests is a research process wherein, we collect data through the readily available information. In this process we use various paid and unpaid databases which our team has access to and gather data through the same. This includes examining of listed companies’ annual reports, Journals, SEC filling etc. Apart from this our team has access to various associations across the globe across different industries. Lastly, we have exchange relationships with various university as well as individual libraries.

Secondary Research

Step 2: Primary Research

When we talk about primary research, it is a type of study in which the researchers collect relevant data samples directly, rather than relying on previously collected data.  This type of research is focused on gaining content specific facts that can be sued to solve specific problems. Since the collected data is fresh and first hand therefore it makes the study more accurate and genuine.

We at SNS Insider have divided Primary Research into 2 parts.

Part 1 wherein we interview the KOLs of major players as well as the upcoming ones across various geographic regions. This allows us to have their view over the market scenario and acts as an important tool to come closer to the accurate market numbers. As many as 45 paid and unpaid primary interviews are taken from both the demand and supply side of the industry to make sure we land at an accurate judgement and analysis of the market.

This step involves the triangulation of data wherein our team analyses the interview transcripts, online survey responses and observation of on filed participants. The below mentioned chart should give a better understanding of the part 1 of the primary interview.

Primary Research

Part 2: In this part of primary research the data collected via secondary research and the part 1 of the primary research is validated with the interviews from individual consultants and subject matter experts.

Consultants are those set of people who have at least 12 years of experience and expertise within the industry whereas Subject Matter Experts are those with at least 15 years of experience behind their back within the same space. The data with the help of two main processes i.e., FGDs (Focused Group Discussions) and IDs (Individual Discussions). This gives us a 3rd party nonbiased primary view of the market scenario making it a more dependable one while collation of the data pointers.

Step 3: Data Bank Validation

Once all the information is collected via primary and secondary sources, we run that information for data validation. At our intelligence centre our research heads track a lot of information related to the market which includes the quarterly reports, the daily stock prices, and other relevant information. Our data bank server gets updated every fortnight and that is how the information which we collected using our primary and secondary information is revalidated in real time.

Data Bank Validation

Step 4: QA/QC Process

After all the data collection and validation our team does a final level of quality check and quality assurance to get rid of any unwanted or undesired mistakes. This might include but not limited to getting rid of the any typos, duplication of numbers or missing of any important information. The people involved in this process include technical content writers, research heads and graphics people. Once this process is completed the title gets uploader on our platform for our clients to read it.

Step 5: Final QC/QA Process:

This is the last process and comes when the client has ordered the study. In this process a final QA/QC is done before the study is emailed to the client. Since we believe in giving our clients a good experience of our research studies, therefore, to make sure that we do not lack at our end in any way humanly possible we do a final round of quality check and then dispatch the study to the client.

Start a Conversation

Hi! Click one of our member below to chat on Phone